Net Cash Provided by (Used in) Financing Activities in USD of GeoVax Labs, Inc. from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
GeoVax Labs, Inc. quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2025.
  • GeoVax Labs, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $7,914,402.
  • GeoVax Labs, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $23,750,516, a 485% increase from 2023.
  • GeoVax Labs, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,062,442, a 89% decline from 2022.
  • GeoVax Labs, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $35,353,328, a 177% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

GeoVax Labs, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $7,914,402 +$7,914,402 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $0 $0 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $0 -$9,229,272 -100% 01 Jan 2023 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q1 2022 $9,229,272 -$3,350,741 -27% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $12,580,013 +$12,282,927 +4134% 01 Jan 2021 31 Mar 2021 10-Q 27 Apr 2022 2022 Q1
Q1 2020 $297,086 +$59,169 +25% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $237,917 -$402,083 -63% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q1 2018 $640,000 +$590,833 +1202% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q1 2017 $49,167 -$189,031 -79% 01 Jan 2017 31 Mar 2017 10-Q 03 May 2018 2018 Q1
Q1 2016 $238,198 -$2,441,611 -91% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2016 2016 Q1
Q1 2015 $2,679,809 01 Jan 2015 31 Mar 2015 10-Q 04 May 2016 2016 Q1
Q1 2013 $1,060,000 -$1,249,192 -54% 01 Jan 2013 31 Mar 2013 10-Q 02 May 2014 2014 Q1
Q1 2012 $2,309,192 01 Jan 2012 31 Mar 2012 10-Q 01 May 2013 2013 Q1

GeoVax Labs, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $23,750,516 +$19,688,074 +485% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025 2024 FY
2023 $4,062,442 -$31,290,886 -89% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025 2024 FY
2022 $35,353,328 +$22,569,116 +177% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 $12,784,212 +$276,396 +2.2% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2020 $12,507,816 +$11,078,073 +775% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2022 2021 FY
2019 $1,429,743 -$60,257 -4% 01 Jan 2019 31 Dec 2019 10-K 23 Mar 2021 2020 FY
2018 $1,490,000 -$61,511 -4% 01 Jan 2018 31 Dec 2018 10-K 24 Mar 2020 2019 FY
2017 $1,551,511 +$211,710 +16% 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2019 2018 FY
2016 $1,339,801 -$1,340,009 -50% 01 Jan 2016 31 Dec 2016 10-K 26 Mar 2019 2018 FY
2015 $2,679,810 +$1,806,410 +207% 01 Jan 2015 31 Dec 2015 10-K 23 Mar 2018 2017 FY
2014 $873,400 -$2,385,731 -73% 01 Jan 2014 31 Dec 2014 10-K 24 Mar 2017 2016 FY
2013 $3,259,131 +$949,939 +41% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2016 2015 FY
2012 $2,309,192 +$1,904,782 +471% 01 Jan 2012 31 Dec 2012 10-K 20 Mar 2015 2014 FY
2011 $404,410 +$834,812 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014 2013 FY
2010 $430,402 01 Jan 2010 31 Dec 2010 10-K 30 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.